Sexually transmitted infections: challenges ahead

M Unemo, CS Bradshaw, JS Hocking… - The Lancet infectious …, 2017 - thelancet.com
WHO estimated that nearly 1 million people become infected every day with any of four
curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and …

Every Newborn: progress, priorities, and potential beyond survival

JE Lawn, H Blencowe, S Oza, D You, ACC Lee… - The lancet, 2014 - thelancet.com
In this Series paper, we review trends since the 2005 Lancet Series on Neonatal Survival to
inform acceleration of progress for newborn health post-2015. On the basis of multicountry …

An update on the global epidemiology of syphilis

N Kojima, JD Klausner - Current epidemiology reports, 2018 - Springer
Abstract Purpose of Review Syphilis continues to cause morbidity and mortality worldwide.
While syphilis infection is easily identifiable and treatable, rates of syphilis infection continue …

Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV …

EA Torrone, CS Morrison, PL Chen, C Kwok… - PLoS …, 2018 - journals.plos.org
Background Estimates of sexually transmitted infection (STI) prevalence are essential for
efforts to prevent and control STIs. Few large STI prevalence studies exist, especially for low …

Does the vaginal microbiota play a role in the development of cervical cancer?

M Kyrgiou, A Mitra, AB Moscicki - Translational Research, 2017 - Elsevier
Persistent infection with oncogenic human papillomavirus (HPV) is necessary but not
sufficient for the development of cervical cancer. The factors promoting persistence as well …

Current treatment of bacterial vaginosis—limitations and need for innovation

CS Bradshaw, JD Sobel - The Journal of infectious diseases, 2016 - academic.oup.com
Practitioners and patients alike widely recognize the limitations of current therapeutic
approaches to the treatment of bacterial vaginosis (BV). Options remain extremely limited …

Association between cervical microbiota and HPV: could this be the key to complete cervical cancer eradication?

E Cascardi, G Cazzato, A Daniele, E Silvestris… - Biology, 2022 - mdpi.com
Simple Summary The microbiota can modulate immune responses and modify the
physiology of the human organism, thereby increasing infective risks and a neoplastic …

Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis

N Van Oostrum, P De Sutter, J Meys… - Human …, 2013 - academic.oup.com
STUDY QUESTION Is bacterial vaginosis (BV) associated with the cause of infertility and
does BV impinge on conception rates and early pregnancy loss following IVF? SUMMARY …

Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on …

M Madanitsa, HC Barsosio, DTR Minja, G Mtove… - The Lancet, 2023 - thelancet.com
Background Intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin–
piperaquine is more effective than IPTp with sulfadoxine–pyrimethamine at reducing malaria …

Microbiome and cervical cancer

CP Castanheira, ML Sallas, RAL Nunes, NPC Lorenzi… - Pathobiology, 2021 - karger.com
Persistent infection with some types of mucosal human papillomavirus (HPV) is the
etiological factor for the development of cervical cancer and its precursor lesions. Besides …